The Company Behind the SR1
Build on a foundation of science and experience
SomniResonance®, formed in 2010, is a medical technology company focusing on the design, development, and the commercialization of proprietary electrotherapeutic technologies for the treatment of diseases and pathological conditions. The management team has over 100 combined years of experience in the medical and healthcare fields.
Mission
SomniResonance® is on mission to integrate new paradigms of medical therapeutics for the reduction of human suffering.
Our vision is to provide a safe, effective, affordable alternative to pharmaceutical treatments for sleep disorders with electrotherapeutic technologies.
Key Personnel
-
F.W. Lawrie, Ph.D. InventorDr. Lawrie has had a long career in in the research, design and development of frequency specific bioelectromagnetic technologies for the treatment of neurological conditions.
In 1992, he founded Energy Medicine Developments (EMD), launching a concerted effort to develop, research, and ultimately market innovative electromagnetic therapies for neurologically based disorders. Dr. Lawrie obtained regulatory approval to market the EnerMed Therapy for the treatment of symptoms of multiple sclerosis and migraine in Canada (License 22473) and supervised the Company’s European representatives and manufacturers in their successful effort to obtain the CE mark for distribution in Europe (CE 59470). Under his leadership EMD obtained nine Institutional Review Board (IRB) approvals for clinical studies investigating the effects of a pulsed electromagnetic field generator on symptoms of multiple sclerosis, migraine and Parkinson’s disease. The Company’s research was supported by $600,000 in grants from the U.S. National Institutes of Health and the Multiple Sclerosis Association of America.
Dr. Lawrie has developed proprietary electromagnetic patterns for use in the treatment of a number of medical conditions. He is experienced in the design and management of clinical research. He has been Co-Investigator and Treatment Consultant in nine IRB approved Clinical Studies investigating the effects of extremely low frequency (ELF) pulsed electromagnetic frequencies (PEMF) on the symptoms of multiple sclerosis, migraine and Parkinson’s disease.
He is a life member of the International Society for Bioelectromagnetism.
Publications and Presentations
Dr F.W. Lawrie
Book Chapters
Lappin, MS and Lawrie, FW (2003). Evidence for the therapeutic effects of a pulsed electromagnetic therapy on Multiple Sclerosis. In MJ McLean, S Engstrom, RR Holcomb (Eds), Magnetotherapy: Potential Therapeutic Benefits and Adverse Effects. New York: TFG Press.
Peer Reviewed Publications
Lappin MS, Lawrie FW, Richards TL, Kramer ED (2003). Effects of a pulsed electromagnetic therapy on Multiple Sclerosis fatigue and quality of life: A double-blind, placebo controlled trial. Alternative Therapies in Health and Medicine, 9(4): 38-48.
Richards TL, Lappin MS, Lawrie FW, Stegbauer KC (1998). Bioelectromagnetic applications for multiple sclerosis. Physical Medicine and Rehabilitation Clinics of North America, 9(3): 659-674.
Richards TL, Lappin MS, Acosta-Urquidi J, Kraft GH, Heide AC, Lawrie FW, Merrill TE, Melton GB, Cunningham CA (1997). Double-blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative and Complementary Medicine, 3(1): 21-29.
Conference Presentations
Lawrie FW (Moderator), Lappin MS, Esty ML. (2006). Neurofunctional Responses to Weak Electromagnetic Fields. Symposium at the 37th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, April 6-9, 2006, Portland, Oregon.
Lappin MS, Lawrie FW. (2001). Preliminary Assessment of the Effects of a Pulsed Electromagnetic Field Therapy on Migraine Headaches. Presentation at the 9th Annual Society for Neuronal Regulation Conference, October 27-30, 2001, Monterey CA. Abstract at:
Lappin MS, Lawrie FW, Richards, TL. (1999). Evidence for the Therapeutic Effects of a Pulsed Electromagnetic Therapy on Multiple Sclerosis. Poster presented at the 1st International Symposium on Potential Therapeutic Applications of Magnetic Fields, Nov 15-16, Vanderbilt University, Nashville, TN.
Lappin MS, Lawrie FW. (1999). Pulsed Electromagnetic Fields: Placebo-Controlled Double Blind Study of the Effects in Multiple Sclerosis. Paper presented at the Tenth International Montreux Congress on Stress, March 1-5, Montreux, Switzerland.
Richards TL, Lappin MS, Kramer ED, Alquist A, Kraft GH, Floyd BE, Stegbauer KC, Lawrie FW (1998). Effects of a Pulsed Magnetic Field Therapy on Multiple Sclerosis Symptoms. Paper presented at the Consortium of Multiple Sclerosis Centers annual meeting, Oct 1-3, 1998, Cleveland OH.
Richards TL, Acosta-Urquidi J, Merrill TE, Kraft GH, Lappin MS, Lawrie FW (1997). Pulsing Magnetic Field Treatment Effects on Brain Electrical Activity in Multiple Sclerosis. Paper presented at the Consortium of Multiple Sclerosis Centers Conference, Systems of Care in Multiple Sclerosis, Sep 5-7, 1997, Calgary, Alberta Canada. Abstract appears in Multiple Sclerosis, 3(3), 1997.